Danaher Corp 2025 SR
The report highlights Danaher's progress in 2024 across its biotechnology, diagnostics, and life sciences segments. Key achievements include a 31% reduction in Scope 1 and 2 greenhouse gas emissions compared to a 2021 baseline and a commitment to set science-based targets through SBTi. The company invested $1.6 billion in research and development, focusing on life-saving innovations like the first point-of-care test for Hepatitis C. Additionally, Danaher achieved a 76% internal fill rate for senior leadership roles and assessed 76% of its supplier spend through EcoVadis.
Company: Danaher Corp
Sector: Health Care
Country: United States
Year: 2025
Type: SR
Pages: 65
Danaher Corp
Sustainability Report
The report highlights Danaher's progress in 2024 across its biotechnology, diagnostics, and life sciences segments. Key achievements include a 31% reduction in Scope 1 and 2 greenhouse gas emissions compared to a 2021 baseline and a commitment to set science-based targets through SBTi. The company invested $1.6 billion in research and development, focusing on life-saving innovations like the first point-of-care test for Hepatitis C. Additionally, Danaher achieved a 76% internal fill rate for senior leadership roles and assessed 76% of its supplier spend through EcoVadis.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
May 31, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Workplace Fatalities
Net Zero Target
Employees